Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
HYUGA PRIMARY CARE Co.,Ltd. (7133.T)
Kasuga, JP
HYUGA PRIMARY CARE Co.,Ltd., established in 2007 and based in Kasuga, Japan, specializes in delivering a variety of primary care services, encompassing home-visit pharmacies, nursing support, and personalized care planning. The company extends its expertise to small and medium-sized pharmacy operators, equipping them with the necessary knowledge, technological systems, staffing solutions, and sales strategies to launch and manage their home visiting pharmacy operations. This includes providing their "Fam Care" home visit support information system, offering on-call system assistance, and guiding them in home palliative care. Furthermore, HYUGA PRIMARY CARE manages "Tai Support," an online platform that aids medical social workers in locating suitable senior housing options, such as assisted living facilities, private nursing homes, and group homes. The firm also develops the "Mimamori ICT Robot Terminal," a wearable device specifically designed for nursing care facilities. In addition to these services, it directly operates its own home visiting pharmacy, delivering prescription medications straight to patients' residences, and plays a significant role in the broader primary care home sector. The company changed its name from Hyuga Pharmacy Co., Ltd. to HYUGA PRIMARY CARE Co.,Ltd. in October 2020.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.54% | -17.60% | -19.23% | -18.86% | -15.59% | -21.83% | -42.81% | -55.45% | -58.57% | -58.57% | -58.57% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Care Facilities: +10.2%+20.0% ★ Q1'26: +20.4% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%-30.2% Q1'26: -21.2% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+1.1% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%+6.8% Q1'26: +12.4% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%+12.2% ★ Q1'26: +27.6% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%-0.1% ★ Q1'26: -0.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×2.72× Q1'26: 1.60× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|
| Revenue |
5.78B
est: 5.80B (-0.3%)
|
6.66B
est: 6.90B (-3.5%)
|
8.29B
est: 8.32B (-0.4%)
|
9.98B
est: 9.95B (+0.3%)
|
11.70B
11.70B – 11.70B
+17.6% YoY
|
13.20B
13.20B – 13.20B
+12.8% YoY
|
| EBITDA |
568.69M
est: 553.81M (+2.7%)
|
627.27M
est: 658.84M (-4.8%)
|
854.38M
est: 794.14M (+7.6%)
|
1.31B
est: 1.05B (+25.0%)
|
1.23B
1.23B – 1.23B
+17.6% YoY
|
1.39B
1.39B – 1.39B
+12.8% YoY
|
| EBIT |
489.83M
est: 441.89M (+10.8%)
|
536.08M
est: 525.70M (+2.0%)
|
664.58M
est: 633.66M (+4.9%)
|
1.02B
est: 828.00M (+23.6%)
|
973.63M
973.63M – 973.63M
+17.6% YoY
|
1.10B
1.10B – 1.10B
+12.8% YoY
|
| Net Income |
328.45M
est: 371.19M (-11.5%)
|
382.88M
est: 462.61M (-17.2%)
|
441.03M
est: 613.87M (-28.2%)
|
719.03M
est: 767.49M (-6.3%)
|
1.02B
1.02B – 1.02B
+33.4% YoY
|
1.32B
1.32B – 1.32B
+28.5% YoY
|
| SGA |
699.00M
est: 765.46M (-8.7%)
|
1.02B
est: 910.63M (+11.7%)
|
1.17B
est: 1.10B (+6.7%)
|
1.36B
est: 1.33B (+1.7%)
|
1.57B
1.57B – 1.57B
+17.6% YoY
|
1.77B
1.77B – 1.77B
+12.8% YoY
|
| EPS |
47.90
est: 50.55 (-5.2%)
|
53.92
est: 63.00 (-14.4%)
|
62.05
est: 83.60 (-25.8%)
|
101.12
est: 104.60 (-3.3%)
|
139.50
139.50 – 139.50
+33.4% YoY
|
179.30
179.30 – 179.30
+28.5% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-14 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-13 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-12 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-11 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-08 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-07 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-01 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-30 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-28 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-27 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-24 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-23 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-22 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-21 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-20 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-17 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-16 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Kohei Shiroo | GM of Medical & Nursing Care Collaboration Business Headquarters and Director | — | male |
| Satoshi Kuroki | President, Chief Executive Officer & Representative Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 7133.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
